Stay updated on Presendin in IIH Study: Clinical Trial
Sign up to get notified when there's something new on the Presendin in IIH Study: Clinical Trial page.

Latest updates to the Presendin in IIH Study: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPremier Research added and revision updated to v3.3.2; Premier Research Group plc removed and revision updated to v3.2.0; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedDeleted the government funding lapse notice banner from the page; the trial details and eligibility information remain unchanged.SummaryDifference0.3%

- Check42 days agoChange DetectedThe IIH EVOLVE trial NCT05347147 has been terminated following a strategic evaluation. The study record now reflects termination and updated study dates.SummaryDifference0.4%

- Check71 days agoChange DetectedAdds a government operating status notice and a v3.2.0 revision tag; removes the specific resource Benign intracranial hypertension (v3.1.0).SummaryDifference2%

- Check78 days agoChange DetectedSummary of changes: updated the revision from v3.0.2 to v3.1.0 and added a new topic (Benign intracranial hypertension); several MedlinePlus topic deletions were removed from the page.SummaryDifference0.5%

- Check92 days agoChange DetectedThe page now shows Revision: v3.0.2 instead of v3.0.1, and the 'Back to Top' element was removed. No changes to core content or critical data.SummaryDifference0.1%

Stay in the know with updates to Presendin in IIH Study: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Presendin in IIH Study: Clinical Trial page.